在流量转移中管理血栓形成风险:对抗血小板方法的审查
Aureliana Toma1, Muhammed Amir Essibayi1,2, Mahmoud Osama3,4
1Department of Radiology, Montefiore Medical Center, Albert Einstein College of Medicine, USA.
The neuroradiology journal
|January 8, 2025
概括
优化抗血小板治疗,包括双抗血小板治疗 (DAPT),对于脑动脉瘤治疗中的流量转移至关重要. 个性化策略和血小板功能测试是平衡疗效和安全的关键.
科学领域:
- 神经干预外科手术 神经干预外科
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 流量转移是内动脉瘤的关键治疗方法,但其成功取决于抗血小板治疗.
- 最佳的抗血小板策略,包括双抗血小板治疗 (DAPT) 时间和器件数,尚未确定.
- 标准的DAPT (阿司匹林加上丁胺) 平衡了凝块预防和出血风险.
研究的目的:
- 审查当前的抗血小板策略,用于内动脉瘤的流量转移.
- 讨论个性化医学和新兴技术在优化治疗中的作用.
- 强调平衡治疗疗效与出血风险的重要性.
主要方法:
- 对流量转移程序中的抗血小板治疗现有文献的综述.
- 分析不同抗血小板药物 (克洛皮多格雷尔,普拉苏格雷尔,蒂卡格雷勒) 和它们的疗效.
- 考虑影响治疗的因素,包括遗传多形态和破裂动脉瘤.
主要成果:
- 患者对克洛皮多格雷尔的可变反应需要个性化抗血小板疗法.
- 普拉苏格勒和提卡格勒提供了具有特定好处和风险的替代品.
- 血小板功能测试对于定制治疗和管理风险至关重要.
结论:
- 个性化抗血小板药物治疗,考虑到支架药物相互作用,对于最佳结果至关重要.
- 新兴技术,如药物释放支架和P2Y12逆转剂,可能会改进未来的策略.
- 需要继续进行研究和合作,以提高流量转移的安全性和有效性.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...


